BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 164 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $660 | -20.6% | 13,151 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $831 | +24.4% | 13,151 | -11.4% | 0.00% | 0.0% |
Q1 2023 | $668 | +48.8% | 14,851 | +44.9% | 0.00% | +33.3% |
Q4 2022 | $449 | -99.9% | 10,251 | +7.3% | 0.00% | -25.0% |
Q3 2022 | $629,000 | +30.5% | 9,551 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $482,000 | -21.0% | 9,551 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $610,000 | -40.4% | 9,551 | 0.0% | 0.00% | -40.0% |
Q4 2021 | $1,023,000 | -17.4% | 9,551 | -20.7% | 0.01% | -16.7% |
Q3 2021 | $1,239,000 | +16.9% | 12,051 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $1,060,000 | +20.5% | 12,051 | +33.1% | 0.01% | +20.0% |
Q1 2021 | $880,000 | -13.3% | 9,051 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $1,015,000 | +21.0% | 9,051 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $839,000 | -40.6% | 9,051 | -50.0% | 0.01% | 0.0% |
Q2 2020 | $1,412,000 | -52.4% | 18,102 | -52.4% | 0.01% | -83.3% |
Q3 2018 | $2,966,000 | +145.9% | 38,000 | +100.0% | 0.04% | +50.0% |
Q2 2018 | $1,206,000 | – | 19,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |